Profile of the licensing and start-up efforts of JHU, including an extended discussion of Lion Pharmaceuticals Inc.

Are the rules which European university technology transfer offices follow in structuring deals different than those of their counterparts in the US?

Savvy venture capitalists, biotech firms, and pharmaceutical companies have long recognized universities as technology troves of untapped value. In the last year or so, universities have developed a heightened perception of their own value--and are increasingly willing to exploit it through creative dealmaking. A look at the previous six months of licenses and research agreements signed between universities and pharmaceutical companies.

The U. of Pittsburgh aims to keep its start-ups near Pittsburgh.